Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -68.57% and 68.81%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...

Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $34.5 million in its fourth quarter. On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 59 cents. The ...

Reports Q4 revenue $$6.278M, consensus $16.58M.” Over the past year, Voyager has significantly advanced our two wholly-owned programs targeting ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Elanco Animal Health (ELAN – Research ...

VOYAGER THERAPEUTICS ($VYGR) is expected to release its quarterly earnings data on Tuesday, March 11th after market close, per Finnhub. Analysts are expecting revenue ...

S&P 500 E-Mini futures (ESH25) are up +0.41%, andMarch Nasdaq 100 E-Mini futures (NQH25) are up +0.53% this morning, pointing ...

CytomX Therapeutics (CTMX) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of a loss of $0.20 per share. This compares to earnings of $0.01 per share a year ...

Explore the detailed Voyager Therapeutics Inc balance sheet to understand the company’s financial health and stability. This page provides a clear breakdown of key metrics, including total ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.